UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging

Clinical imaging, 2017-03, Vol.42, p.126-132

2017

Volltextzugriff (PDF)

Twins in spirit part II: DOTATATE and high-affinity DOTATATE—the clinical experience

European journal of nuclear medicine and molecular imaging, 2014-06, Vol.41 (6), p.1158-1165

2014

Volltextzugriff (PDF)

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters

European journal of nuclear medicine and molecular imaging, 2002-10, Vol.29 (10), p.1317-1323

2002

Volltextzugriff (PDF)

PET/MRI in head and neck cancer: initial experience

European journal of nuclear medicine and molecular imaging, 2013-01, Vol.40 (1), p.6-11

2013

Volltextzugriff (PDF)

Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma

Journal of Nuclear Medicine, 2015-08, Vol.56 (8), p.1150-1156

2015

Volltextzugriff (PDF)

FDG PET Can Replace Bone Scintigraphy in Primary Staging of Malignant Lymphoma

The Journal of nuclear medicine (1978), 1999-09, Vol.40 (9), p.1407-1413

1999

Volltextzugriff (PDF)

Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications

Neurology, 2016-01, Vol.86 (3), p.231

2016

Volltextzugriff (PDF)

Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure

Acta oncologica, 2015-10, Vol.54 (9), p.1355-1363

2015

Volltextzugriff (PDF)

Effects of Positive End-Expiratory Pressure and Spontaneous Breathing Activity on Regional Lung Inflammation in Experimental Acute Respiratory Distress Syndrome

Critical care medicine, 2019-04, Vol.47 (4), p.e358

2019

Volltextzugriff (PDF)

Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction

Magma (New York, N.Y.), 2013-02, Vol.26 (1), p.115-126

2013

Volltextzugriff (PDF)

Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics

Current drug delivery, 2009-07, Vol.6 (3), p.255

2009

Volltextzugriff (PDF)

FDG PET/MR for lymph node staging in head and neck cancer

European journal of radiology, 2014-07, Vol.83 (7), p.1163-1168

2014

Volltextzugriff (PDF)

Effect of [18 F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice

Radiotherapy and oncology, 2014-04, Vol.111 (1), p.81-87

2014

Volltextzugriff (PDF)

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy

Radiotherapy and oncology, 2017-03, Vol.122 (3), p.437-444

2017

Volltextzugriff (PDF)

PET/MR for therapy response evaluation in malignant lymphoma: initial experience

Magma (New York, N.Y.), 2013-02, Vol.26 (1), p.49-55

2013

Volltextzugriff (PDF)

Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease

Neurology, 2013-05, Vol.80 (19), p.1754

2013

Volltextzugriff (PDF)

Enhanced Tumor Uptake in Neuroendocrine Tumors After Intraarterial Application of 131I-MIBG

The Journal of nuclear medicine (1978), 2005-12, Vol.46 (12), p.2112-2116

2005

Volltextzugriff (PDF)

Final Results of the Prospective Biomarker Trial PETra: [ 11 C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma

Clinical cancer research, 2021-03, Vol.27 (5), p.1351-1360

2021

Volltextzugriff (PDF)

Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET

The Journal of nuclear medicine (1978), 2000-10, Vol.41 (10), p.1695-1701

2000

Volltextzugriff (PDF)

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer

Radiotherapy and oncology, 2012-10, Vol.105 (1), p.21-28

2012

Volltextzugriff (PDF)

Evaluation of Neoadjuvant Therapy Response of Osteogenic Sarcoma Using FDG PET

The Journal of nuclear medicine (1978), 1999-10, Vol.40 (10), p.1637-1643

1999

Volltextzugriff (PDF)

Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2381-2389, Article 2381

1999

Volltextzugriff (PDF)

Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG

The Journal of nuclear medicine (1978), 2003-09, Vol.44 (9), p.1426-1431

2003

Volltextzugriff (PDF)

188Re or 90Y‐labelled anti‐CD66 antibody as part of a dose‐reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study

British journal of haematology, 2005-08, Vol.130 (4), p.604-613

2005

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)
Japanisch
(10)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(78)
Male
(68)
Life Sciences & Biomedicine
(65)
Science & Technology
(65)
Middle Aged
(63)
Aged
(46)
Adult
(42)
Radiology, Nuclear Medicine & Medical Imaging
(42)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Oncology
(28)
Fluorodeoxyglucose F18
(23)
Adolescent
(17)
Radiopharmaceuticals
(17)
Prospective Studies
(14)
Positron-Emission Tomography
(13)
Positron-Emission Tomography - Methods
(13)
Treatment Outcome
(13)
Aged, 80 And Over
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging

Twins in spirit part II: DOTATATE and high-affinity DOTATATE—the clinical experience

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters

PET/MRI in head and neck cancer: initial experience

Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma

FDG PET Can Replace Bone Scintigraphy in Primary Staging of Malignant Lymphoma

Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications

Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure

Effects of Positive End-Expiratory Pressure and Spontaneous Breathing Activity on Regional Lung Inflammation in Experimental Acute Respiratory Distress Syndrome

Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction

Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics

FDG PET/MR for lymph node staging in head and neck cancer

Effect of [18 F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy

PET/MR for therapy response evaluation in malignant lymphoma: initial experience

Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease

Enhanced Tumor Uptake in Neuroendocrine Tumors After Intraarterial Application of 131I-MIBG

Final Results of the Prospective Biomarker Trial PETra: [ 11 C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma

Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer

Evaluation of Neoadjuvant Therapy Response of Osteogenic Sarcoma Using FDG PET

Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG

188Re or 90Y‐labelled anti‐CD66 antibody as part of a dose‐reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study

Aktive Filter

Suchergebnisse filtern